- Opthea website has added the presentation from the New York forum “Beyond anti-VEGF-A for retinal diseases” which can be listened to. Runs for close to 2hrs!
Ann: Opthea Reports Positive Data from Ph1b DME Study of OPT-302, page-6
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.5¢ |
Change
-0.020(4.04%) |
Mkt cap ! $594.0M | |||
| Open | High | Low | Value | Volume |
| 49.5¢ | 50.8¢ | 47.5¢ | $267.1K | 550.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 29597 | 47.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.5¢ | 15044 | 2 |
View Market Depth
| Last trade - 16.10pm 20/08/2024 (20 minute delay) ? |
| OPT (ASX) Chart |